GPT and metabolic dysfunction-associated steatotic liver disease: Despite the lack of clarity surrounding the ALT cut-off values associated with NAFLD, our study has demonstrated that a one-unit increase in ALT, an established biomarker, is associated with an increased risk of NAFLD, with an odds ratio of 1.081 (95% CI: 1.016–1.149).